A light probe helped surgeons see tumor the dye missed
Original title: Intraoperative Tumor-Tissue Discrimination and Histology-Defined Glioma Grading Using Combined Fluorescence and Diffuse Reflectance Spectroscopy.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
It was tried in a small group during surgery, but it is not approved or in normal use.
The short version
A handheld light probe found brain tumor at spots where the usual glowing dye showed nothing.
What was studied. Thirty-three people with glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary had surgery guided by 5-ALA: A medicine you are given before some brain operations. The tumor soaks it up. Under a special light the tumor then glows, so the surgeon can see where it stops and healthy brain starts. See the glossary, a drug that makes tumor glow. Doctors also touched a handheld probe to the brain. The probe shines light on tissue and reads the light that comes back.
What they found. The team took readings at 212 spots and checked them against lab tests of the tissue. Using both kinds of light reading together worked better than using either one alone. The probe spotted tumor at 55 of 65 spots that did not glow with the dye. That included 19 of 23 spots from low grade tumors. The probe was right less often when it tried to tell low grade from high grade tumors.
What this means, and what it doesn't
What it could mean: The glowing dye can miss tumor, and this probe picked up some of what it missed. In time, a tool like this might help surgeons find the edge of a tumor. That could help them remove more of it safely.
What it doesn't mean: This does not mean the probe is ready for your surgery. It is early work in a small group at one center. The probe is not approved and is not part of normal care. The study did not show that people lived longer or felt better. The authors say bigger studies at more hospitals are needed first. This is not a cure.
Source: PubMed, November 2, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.